Marketing Authorization Application of Pertussis, Diphtheria, Tetanus, Inactivated Polio and Hib Combined Vaccine (BK1310/MT-2355)
April 11, 2022
Mitsubishi Tanabe Pharma Corporation, a member of the Mitsubishi Chemical Holdings Group, has announced the following press release.
■Mitsubishi Tanabe Pharma Press Release
■Mitsubishi Tanabe Pharma Press Release
Marketing Authorization Application of Pertussis, Diphtheria, Tetanus, Inactivated Polio and Hib Combined Vaccine (BK1310/MT-2355)
